Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Similar documents
ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure

Κατάλυση παροξυσμικής κολπικής μαρμαρυγής Ποια τεχνολογία και σε ποιους ασθενείς; Χάρης Κοσσυβάκης Καρδιολογικό Τμήμα Γ.Ν.Α. «Γ.

Ablation Should Not Be Used as Primary Therapy for Treatment of Patients with Atrial Fibrillation

Rebuttal. Jerónimo Farré MD 2010

AF Today: W. For the majority of patients with atrial. are the Options? Chris Case

In Whom and When Should Atrial Fibrillation Ablation be Considered?

علم االنسان ما لم يعلم

Catheter ablation in AF patients with heart failure. What is possible?

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

AF Ablation in Patients with Heart Failure

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

La terapia non anticoagulante nel paziente con FA secondo le Linee Guida F. CONROTTO

Interventional solutions for atrial fibrillation in patients with heart failure

ABLATION OF CHRONIC AF

AF Ablation in 2015 Why, Who, What and How? Steve Wilton ACC Rockies, Banff March 10, 2015

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Rate and Rhythm Control of Atrial Fibrillation

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial fibrillation: Who should be referred for ablation therapy for atrial fibrillation?. September 12 th, 2015

A Cryo Anatomical Procedure to Everyone? Saverio Iacopino, FACC, FESC

AF ABLATION Concepts and Techniques

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Who Gets Atrial Fibrilla9on..?

Catheter ablation of atrial fibrillation: Indications and tools for improvement of the success rate of the method. Konstantinos P.

Recent observations have focused attention on the PVs as a source of ectopic activity i determining i AF

Treatment of Atrial Fibrillation in Heart Failure

Ο ΡOΛΟΣ ΤΗΣ ΑΠΕΙΚOΝΙΣΗΣ ΣΤΗΝ ΗΛΕΚΤΡΟΦΥΣΙΟΛΟΓIΑ - ΥΠΟΣΤΡΩΜΑ ΚΟΛΠΟΙ ΩΤΙΑ ΑΞΙΟΛΟΓΗΣΗ ΟΥΛΗΣ

Catheter Ablation: Atrial fibrillation (AF) is the most common. Another Option for AF FAQ. Who performs ablation for treatment of AF?

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Role of Ablation of AF and PVCs in the Management of Heart Failure

PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE. PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

Rate vs. Rhythm Control in Atrial Fibrillation

Long-Term ECG Monitoring Using an ILR. Evgeny Pokushalov, MD, PhD

Catheter Ablation of Atrial Fibrillation Strategy and Outcome Predictors Shih-Ann Chen MD

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Stand alone maze: when and how?

Debate PRO. Dronedarone is an important drug in the management of paroxysmal atrial fibrillation. John Camm

Raphael Rosso MD, Yuval Levi Med. Eng., Sami Viskin MD Tel Aviv Sourasky Medical Center

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

What s New in the Guidelines for Surgical Ablation for Atrial Fibrillation?

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD

Long-Term Atrial Fibrillation Progression: What We Know in 2014

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

Advanced imaging of the left atrium - strain, CT, 3D, MRI -

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.

Primary Mitral Regurgitation

The 5 Most Important Things You Need to Know About Atrial Fibrillation. John D. Day, MD Director, Intermountain Heart Rhythm Specialists

Controversies in Atrial Fibrillation and HF

Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing

When to ablate patients with premature ventricular complexes?

Role of LAA isolation in AF cure

Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation Executive Summary

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF)

Importance of CRT team for optimization of the results: a European point of view

Innovations in AF Management

First question: Does CRT Work in AF?

Individualised strategy approach to AF ablation

What s new in my specialty?

Linear Ablation Should Not Be a Standard Part of Ablation in Persistent AF. Disclosures. LA Ablation vs. Segmental Ostial Ablation With PVI for PAF

Modern management of atrial fibrillation, from blood pressure control to anticoagulation

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Atrial fibrillation and advanced age

Combined catheter ablation and left atrial appendage closure as a. treatment of atrial fibrillation

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Outcomes of AF Ablation

Should hybrid ablation be the standard of care instead of transcatheter ablation techniques?

Possible clinical and hemodynamic predictors of atrial fibrillation recurrence after catheter ablation

Catheter ablation is not a class I indication after failed antiarrhythmic drugs

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

Long Standing Persistent AF ; CPVI is enough for it

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Atrial Cardiomyopathy is it relevant?

Catheter Ablation of Arrhythmias: Are the Results Different in the Elderly Patients?

How atrial fibrillation should be treated in the heart failure patient?

Atrial Fibrillation. Ivan Anderson, MD RIHVH Cardiology

Large RCT s of CRT 2002 to present

Ablation of persistent AF Is it different than paroxysmal?

Management of Atrial Fibrillation in Heart Failure

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Contemporary Strategies for Catheter Ablation of Atrial Fibrillation

Prognostic Value of Left Atrial Size and Function

Μηνύματα από τις σπουδαιότερες μελέτες στην ηλεκτροφυσιολογία το διάστημα

Mitral Valve prolapse: What s new? Which indications of early surgery? Input of new 2017 ESC/EACTS guidelines. Christophe Tribouilloy Amiens, France

FA et Apnée du Sommeil

» A new drug s trial

How Should we Select Patients for Catheter Ablation? Douglas Esberg, MD, FHRS

Long-Term Outcome and Risks of Catheter Ablation for Atrial Fibrillation

Catheter ablation of AF Where do we stand, where do we go?

부정맥 3 Debaste 2. 08:30~10:00: 4 회의장

ICD THERAPIES: are they harmful or just high risk markers?

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

Load and Function - Valvular Heart Disease. Tom Marwick, Cardiovascular Imaging Cleveland Clinic

Left atrial function. Aliakbar Arvandi MD

Aortic stenosis aetiology: morphology of calcific AS,

Transcription:

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES

AF: the kingdom of wishful thinking In AF we hold beliefs and make decisions not based on evidences, that are lacking, but on what we consider rational in spite of not being scientifically demonstrated

Catheter ablation (guidelines 2006) Catheter ablation is a reasonable alternative to pharmacological therapy to prevent recurrent AF in symptomatic patients with little or no LA enlargement. (class IIa, LOE C) LOE C and rather vague statements Circulation. 2006;114:700-752 1. For rhythm control, drugs are typically the first choice and LA ablation is a second-line choice 2. In some patients, especially young persons with very symptomatic AF who need sinus rhythm, radiofrequency ablation may be preferred over years of drug therapy 3. Catheter ablation should be considered to maintain sinus rhythm in selected patients who failed to respond to antiarrhythmic drug therapy

What do we know? 1.Rhythm control has not been shown to be better than rate control, but 2.Ablation is more successful than AAD Rx in maintaining SR 3.AF begets AF in the experimental setting 4.Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5.Successful ablation reduces LA dimensions, does not seem to impair atrial function, and improves systolic LV function

What do we know? 1.Rhythm control has not been shown to be better than rate control, but 2.Ablation is more successful than AAD Rx in maintaining SR 3.AF begets AF in the experimental setting 4.Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5.Successful ablation reduces LA dimensions, does not seem to impair atrial function, and improves systolic LV function

AFFIRM on treatment analysis Circulation. 2004;109:1509-1513 In an intention-to-treat analysis, AFFIRM showed that rhythm-control offered no survival advantage over rate-control and that there were potential advantages with rate-control (lower risk of adverse drug effects) on-treatment analysis of the relation of survival to cardiac rhythm and treatment 1. Warfarin improves survival 2. SR is a determinant of survival (HR 0.53) or a marker for other factors associated with survival 3. AADs increase mortality (HR 1.49) If an effective method for maintaining SR with fewer adverse effects were available, it might be beneficial

What do we know? 1.Rhythm control has not been shown to be better than rate control, but 2.Ablation is more successful than AAD Rx in maintaining SR 3.AF begets AF in the experimental setting 4.Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5.Successful ablation reduces LA dimensions, does not seem to impair atrial function, and improves systolic LV function

RFCA better than AAD Rx for RC J Cardiovasc Med 2010, 11:408 418 Eur Heart J 2010; 31: 1046 1054 Circ Arrhyth Electrophysiol. 2009;2:349-361 controlled and historical studies have shown that ablation is more successful than AAD therapy in maintaining sinus rhythm

Meta-analysis: RFCA vs AAD Rx Jerónimo Farré MD 2010 the results of this metaanalysis [8 studies] favor ablation over AAD therapy J Cardiovasc Med 2010, 11:408 418

What do we know? 1.Rhythm control has not been shown to be better than rate control, but 2.Ablation is more successful than AAD Rx in maintaining SR 3.AF begets AF in the experimental setting 4.Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5.Successful ablation reduces LA dimensions, does not seem to impair atrial function, and improves systolic LV function

Experimental AF results in molecular, electrophysiological, and structural changes in the atrial myocytes and interstitial matrix that facilitate perpetuation of AF It would be rational to intervene at a time the AF-induced remodeling is minimal Experimental studies on AF Circulation 1995; 91: 1588-95 Circulation 1997;96:3157-3163 Circulation 1999;100:87-95 J Am Coll Cardiol 2006; 47:644-653

What do we know? 1.Rhythm control has not been shown to be better than rate control, but 2.Ablation is more successful than AAD Rx in maintaining SR 3.AF begets AF in the experimental setting 4.Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5.Successful ablation reduces LA dimensions, does not seem to impair atrial function, and improves systolic LV function

LA remodeling in AF MRI DE in 81 pts 41 PAF 40 persistent AF Mild LE ( 15% of the LA) 43 Moderate LE (15-35% of LA) 30 Extensive LE (>35% of LA) 8 Nassir F Marrouche Circulation. 2009;119:1758-1767 All patients with extensive LE had persistent AF

LA remodeling in AF Extensive LE and large low voltage areas Circulation. 2009;119:1758-1767 32% 63%

LA remodeling and recurrence there seems to be a relation between the duration of AF, the extent of remodelling, and the risk of recurrence of AF after catheter ablation Circulation. 2009;119:1758-1767

LA remodeling in AF: limitations Nassir F Marrouche Circulation. 2009;119:1758-1767 1. Sample size relatively small 2. Technology complex and subjected to potential inaccuracies - Software used - Investigators (selection of thresholds for the algorithm of detection) - Limited spatial resolution of 1.5T MRI scanner - Respiratory artifacts - MRI noise

Ongoing studies: DECAAF Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation multi-center, 1-year prospective cohort study (1 year follow-up, at 3, 6 and 12 month) recruiting 675 participants DE-MRI within 30 days prior to the AF ablation procedure to quantify atrial structural remodeling or fibrosis pre-ablation DE-MRI at 3, 6, and 12 months follow-up to detect and quantify ablation-related scar formation Study Start Date July 2010 Estimated Study Completion Date June 2012

What do we know? 1.Rhythm control has not been shown to be better than rate control, but 2.Ablation is more successful than AAD Rx in maintaining SR 3.AF begets AF in the experimental setting 4.Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5.Successful ablation reduces LA dimensions, does not seem to impair atrial function, and improves systolic LV function

Effect of ablation on LA in AF Am J Cardiol 2010;105:1317 1326 Meta-analysis from 17 studies (enrolling 869 patients) 1. significant decreases in LA diameter and volumes only in successful cases 2. no significant differences in LA ejection fraction and active emptying fraction in successful cases but both decreased in patients with AF recurrence

Limitations of studies on remodeling 1. Variations in - imaging techniques - methodologies of measurement - ablation strategies - amount of scar - follow-up durations - duration of sinus rhythm post ablation - degree of AF burden 2. LA function measured only during sinus rhythm - only in patients in sinus rhythm at the time of imaging before and after ablation - 1-2 days post ablation as control [?]

Reverse remodeling after RFCA Michel Haïssaguerre 48 patients with isolated AF studied by serial ECHOCG at baseline and at 1-, 3-, 6-, 9-, and 12-month intervals after radiofrequency ablation Circulation. 2005;112:2896-2903

LV reverse remodeling & normal EF 30 pts isolated paroxysmal AF [AF] 30 controls [C] ECHO before and at 1-day, 1-m, 6-m, 12-m after RFCA LV systolic function: LVEF & 2-D strain Before ablation - LVEF, transverse & radial strains normal in [AF] and [C] - global longitudinal & circumferential strains lower in [AF] than [C] At 12 months - global longitudinal & circumferential strains were significantly improved in [AF] Michel Haissaguerre Am J Cardiol 2009;103:232 237 1. Pts with PAF and normal LVEF have systolic function abnormalities 2. These abnormalities improve after AF ablation

AF and HeF: candidates to RFCA? 58 consecutive patients with AF and - Hx of congestive heart failure and - LVEF <45% undergoing catheter ablation for AF 58 control patients without heart failure who underwent ablation for AF matched according to age, sex, and type AF Michel Haissaguerre N Engl J Med 2004;351:2373-83. Restoration and maintenance of sinus rhythm by catheter ablation without the use of drugs in patients with congestive heart failure and AF significantly improved cardiac function, symptoms, exercise capacity, and quality of life.

AF and HeF: candidates to RFCA? N Engl J Med 2004;351:2373-83. LVEF after Ablation in Heart Failure

Conclusions 1. In spite that rhythm control has not been shown to be better than rate control, SR maintenance is a marker for an improved survival 2. Ablation is more successful than AAD Rx in maintaining SR 3. AF begets AF 4. Atrial remodeling is greater in permanent than in paroxysmal AF, and the degree of atrial remodeling predicts post-ablation recurrence of AF 5. Successful ablation reduces LA dimensions without impairing atrial function, and improves systolic LV function The sooner the better delaying ablation too much may reduce its efficacy